Epilepsy

FOXJ3 gene identified as the critical link between abnormal brain development and epilepsy

by

Unlocking the Brain’s “Master Switch”: New Hope for Drug-Resistant Epilepsy A groundbreaking discovery has pinpointed mutations in the FOXJ3 gene as a key driver of focal cortical dysplasia (FCD), a leading cause of drug-resistant epilepsy. Researchers have described FOXJ3 as a “master switch” that, when malfunctioning, disrupts the intricate process of brain development, offering new … Read more

Leveraging epileptic network understanding to improve targeted treatment

by

Beyond the Onset Zone: How Mapping the Epileptic Brain is Revolutionizing Treatment For one in three epilepsy patients, medication fails to provide adequate control of seizures. While surgery and neurostimulation offer hope, many still experience recurring seizures. A groundbreaking study published February 13, 2026, in PLOS Biology, sheds light on a new approach: targeting not … Read more

Engineered sensor reveals the brain’s hidden chemical conversations

by

Decoding the Brain: How New ‘Glue Sniffer’ Technology Will Reshape Neuroscience For decades, neuroscientists have been listening to only *half* of the brain’s conversation. They could record the outgoing signals of neurons – the messages they send – but remained largely blind to the incoming signals, the crucial inputs that dictate how the brain processes … Read more

Mount Sinai researchers explore new depression treatment targeting brain’s potassium channels

by

New Hope for Depression Treatment: Targeting Brain Cell Activity For millions battling major depressive disorder, current treatments offer limited relief. But groundbreaking research from the Icahn School of Medicine at Mount Sinai suggests a fundamentally new approach: targeting potassium channels within the brain to modulate brain cell activity. Unlocking the Brain’s Potential: KCNQ Channels and … Read more

Catalyst Pharmaceuticals to Participate in the BofA

by

Exploring the Healthcare Landscape: Catalyst Pharmaceuticals at the BofA Securities Health Care Conference 2025 Catalyst Pharmaceuticals, Inc., a foremost player in the biopharmaceutical sector, stands at the forefront of innovation with its focus on rare and hard-to-treat diseases. Recently, the company announced the participation of its President and CEO, Richard J. Daly, and key management … Read more

Supreme Court debating when students with disabilities can sue schools

by

The Supreme Court and Disability Rights: What Comes Next? The recent Supreme Court ruling, which rejected broader disability reviews for veterans under the ADA, has set a precedent with significant implications for disability rights litigation, especially within education. The case involving Ava Tharpe, a student with a rare form of epilepsy, has drawn the focus … Read more

Epilepsy Drug Resistance Linked to Genetic Variants

by

The Genetic Key to Unlocking Epilepsy Treatment Focal epilepsy, accounting for 61% of epilepsy cases, often resists current medications, leaving two-thirds of patients without relief. A groundbreaking study has identified common genetic variants that could revolutionize epilepsy treatment, offering hope for future breakthroughs. Unraveling the Genetic Mysteries of Drug Resistance A recent study led by … Read more

New genetic clues uncovered in epilepsy drug resistance

by

Decoding Genetic Factors in Focal Epilepsy Drug Resistance Focal epilepsy, marked by seizures originating in one part of the brain, is the most prevalent form of epilepsy. Despite the widespread use of antiseizure medications, approximately one in three individuals—around 20 million globally—experience drug resistance, meaning their seizures persist despite medication. This phenomenon, known as ‘drug … Read more

Newly Discovered Gene Mutation Linked to Neurodevelopmental Disorders

by

The Unseen Architects of Our Genetic Code Recent research has shed light on a groundbreaking discovery: mutations in the non-coding gene RNU2-2 have been identified as a cause of a newly defined neurodevelopmental disorder, often accompanied by severe epilepsy. These findings highlight the critical role played by small, non-coding genes in brain development and could … Read more

Mayo Clinic study highlights a new approach to treating drug-resistant epilepsy

by

The Future of Epilepsy Treatment: AI-Driven Innovations Epilepsy, impacting over 50 million people worldwide, is more than just a neurological disorder; it’s a lived experience often marked by disrupted memory, emotions, and sleep. The introduction of a new approach by researchers at Mayo Clinic using deep brain stimulation (DBS) presents groundbreaking potential, especially for drug-resistant … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]